11 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

THIOGLYCOLLATE ENRICHED

FDA 510(k)
FDA Class 1 ·Microbiology

KORONA

FDA UDI
HNM TOTAL RECON LLC·00841742100708·KORONA Tri Staple - (L)12.5mm, 10mmx8mm

Partial Pelvis Replacement

FDA UDI
WALDEMAR LINK GmbH & Co. KG·04026575048434·5 hole flanges

KEYPATH MRSA/MSSA BLOOD CULTURE TEST-BT

FDA 510(k)
FDA Class 1 ·Microbiology

MEDAMICUS AXIA RSN

FDA 510(k)
FDA Class 2 ·Cardiovascular

ANIMAS INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·May 20, 2014

ENDO RETRACT II 10MM INSTRUMENT

FDA Adverse Event
Malfunction ·COVIDIEN, FORMERLY USSC·Product code GCJ·October 4, 2012

CAPSURE EPI

FDA Adverse Event
Injury ·MEDTRONIC, INC.·Product code DTB·August 31, 2010

BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal specimens Catalog Number: 444213

FDA Enforcement
Class II ·Terminated·Becton Dickinson & Co.·April 21, 2021

PM 1250 and PM 2250 ZENEX; PM1282 and PM2282 ZENEX MRI These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017

PM 1260 ASSURITY + These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017